Risk reduction for small cell cancer of the ovary, hypercalcemic type in prepubertal patient: A clinical and bioethical perspective

Risk reduction for small cell cancer of the ovary, hypercalcemic type in prepubertal patient: A clinical and bioethical perspective

Loss of heterozygosity in the SMARCA4 gene is a hallmark feature of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), an aggressive ovarian cancer occurring in young adults and adolescents with an average age of 23 years and a median survival of less than fifteen months following diagn...

Full description

Bibliographic Details
Main Authors: John A. Vu, Whitney S. Thompson, Denise B. Klinkner, Asma Chattha, Myra Wick, Ellen J. Case, Christopher Collura, Amanika Kumar
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Gynecologic Oncology Reports
Subjects:
Risk-reducing bilateral salpingo-oophorectomy
Rhabdoid tumor predisposition syndrome type 2
Small cell carcinoma of the ovary hypercalcemic type
SMARCA4
BRG1
Four box method
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578923001303

Internet

http://www.sciencedirect.com/science/article/pii/S2352578923001303

Similar Items